TipRanks
Go Ultimate55% OFF

Pharmaron Beijing Co., Ltd. Class H (3759) Income Statement

Pharmaron Beijing Co., Ltd. Class H Income Statement

Last quarter (Q3 2026), Pharmaron Beijing Co., Ltd. Class H's total revenue was $4.41B, an increase of 22.87% from the same quarter last year. In Q3, Pharmaron Beijing Co., Ltd. Class H's net income was $496.85M. See Pharmaron Beijing Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 14.10B$ 12.28B$ 11.54B$ 10.27B$ 7.44B
$ 4.91B$ 4.20B$ 4.12B$ 3.77B$ 2.68B
$ 2.98B$ 2.10B$ 2.28B$ 2.02B$ 1.15B
Depreciation and Amortization$ 1.18B$ 1.05B$ 927.17M$ 696.18M$ 497.92M
$ 3.29B$ 3.38B$ 2.95B$ 2.53B$ 2.49B
$ 1.93B$ 2.10B$ 1.85B$ 1.69B$ 1.91B
$ -15.76M$ -13.20M$ -10.01M$ -23.50M$ -3.34M
$ 1.91B$ 2.09B$ 1.84B$ 1.67B$ 1.91B
$ 1.66B$ 1.79B$ 1.60B$ 1.37B$ 1.66B
Per Share Metrics
Basic EPS$ 0.94$ 1.01$ 1.00$ 0.90$ 1.12
Diluted EPS$ 0.94$ 1.01$ 1.00$ 0.90$ 1.10
Weighted Average Shares Outstanding1.76B1.79B1.77B1.77B1.78B
Weighted Average Shares Outstanding (Diluted)1.77B1.79B1.78B1.78B1.81B

Currency in CNY

Pharmaron Beijing Co., Ltd. Class H Earnings and Revenue History

05B10B15B6 %12 %18 %24 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin